查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1931254

整形外科植入用鎂合金市場：植入類型、材料等級、應用和最終用戶分類，全球預測（2026-2032年）

Magnesium Alloy for Orthopedic Implants Market by Implant Type, Material Grade, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年，用於整形外科植入的鎂合金市場價值為2.3415億美元，預計到2026年將成長至2.5294億美元，複合年成長率為8.27%，到2032年將達到4.0856億美元。

關鍵市場統計數據
基準年 2025 2.3415億美元
預計年份：2026年 2.5294億美元
預測年份 2032 4.0856億美元
複合年成長率 (%) 8.27%

本文全面概述了合金化學、表面工程和臨床證據的進展如何重塑鎂植入在現代整形外科護理中的應用。

鎂合金因其優異的機械性質、生物分解性和與骨癒合生理的相容性，已成為整形外科植入的主要材料之一。合金化學和表面工程的最新進展提高了腐蝕控制能力，使設計人員能夠充分利用其獨特的強度和漸進式吸收特性，這種特性與骨重塑的生物學時間線相吻合。在某些適應症中，這項特性減少了二次取出手術的必要性，為僅需臨時結構支撐的新型治療模式開闢了道路。

來自臨床醫生、監管機構和醫療保健系統的共同需求正在加速鎂基整形外科器材的材料創新和臨床應用。

隨著材料創新、臨床需求和醫療保健系統經濟的融合，整形外科領域正經歷著變革性的轉變。其中顯著的變化包括臨床上越來越重視減輕植入的長期負擔。外科醫生和患者都在尋求能夠在癒合期間提供足夠機械支撐並在癒合後被安全吸收的解決方案，從而避免再次進行植入物取出手術。這種臨床需求推動了鎂合金研究從實驗室到器械原型再到早期臨床應用的進程，而腐蝕控制技術的不斷進步正在緩解先前對鎂合金快速劣化的擔憂。

評估近期關稅政策變化如何重塑鎂植入價值鏈的供應鏈策略、垂直整合和採購決策。

美國近期關稅政策的變化為鎂合金植入物製造商和經銷商的供應鏈帶來了新的變數。關稅調整將影響進口原料、半成品和成品的成本結構，進而影響籌資策略和製造地地點。許多供應商正在積極應對，評估替代採購管道，盡可能提高國內加工能力，並協商簽訂長期合約以規避價格波動風險。

基於全面細分的洞察，植入幾何形狀、臨床應用、通路和材料等級與商業化要求相匹配。

了解產品和臨床細分的細微差別對於優先開發和推出鎂合金植入至關重要。植入類型包括釘、板、棒和釘以及螺絲。板又可細分為加壓板、鎖定板和重組板；棒和釘包括髓內釘和鎖定棒；螺絲則分為鬆質骨螺絲、皮質骨螺絲和自攻螺絲。每種植入幾何形狀都對機械性能和劣化性能有獨特的要求，這些要求會影響合金的選擇、熱處理通訊協定和表面處理技術。

區域監管差異、臨床醫生採納模式和生產能力將如何影響關鍵全球區域的商業化策略

區域趨勢將影響鎂合金植入的監管預期、臨床應用模式和供應鏈策略。在美洲，臨床醫生和醫院系統越來越樂於接受能夠減輕長期手術負擔的創新技術，但這些技術需要可靠的臨床證據和清晰的監管文件。此外，該地區集中採購集團和一體化醫療保健系統能夠加速那些展現出明顯臨床和經濟優勢的產品的推廣應用。

一體化合金研發、卓越製造和臨床夥伴關係是市場領導和細分領域專家的標誌。策略競爭概覽。

鎂植入領域的競爭格局呈現出多元化的態勢：既有老牌整形外科器械製造商向生物可吸收金屬領域拓展，也有專注於合金創新和表面處理技術的材料及組件開發商。領先企業正透過其在合金開發、精密製造和臨床合作方面的綜合能力來加速實證醫學的產生，從而實現差異化競爭優勢。一些公司強調專有的表面塗層和腐蝕控制技術，以實現臨床上可預測的分解曲線；而其他公司則專注於製程控制和認證，以支援大規模生產。

鎂植入製造商可採取的策略重點，以協調臨床證據、供應鏈韌性和針對性的商業化工作

行業領導者應採取多管齊下的策略，將材料的潛力轉化為臨床和商業性的成功。首先，應優先進行有針對性的臨床研究，使植入設計、材料等級選擇和手術技術與外科醫生和支付方真正關心的實際終點指標一致。能夠捕捉功能性結果和再次手術率的實用性試驗和註冊研究尤其重要。其次，應投資加強供應鏈韌性，具體措施包括：實現關鍵原料供應商多元化、認證區域製造合作夥伴以及實施合約保障措施，以降低關稅和物流風險。

該研究詳細描述了調查方法，該方法整合了臨床醫生訪談、材料科學文獻、監管指南和供應鏈分析，以得出經過檢驗的評估。

本分析背後的研究綜合了多種資訊來源，旨在對鎂合金在整形外科植入中的應用進行評估，從而形成一個平衡且基於證據的觀點。主要研究包括：對創傷外科醫生、脊椎外科醫生和顱顎顏面醫生進行結構化訪談；與材料科學家、法規顧問和醫療設備製造商進行對話；以及與供應鏈和分銷相關人員進行直接磋商，以了解採購趨勢。這些定性資訊與已發表的科學文獻、法規指導文件和臨床試驗報告進行交叉比對，以檢驗材料性能聲明和臨床終點。

本文簡要總結了材料技術進步、臨床完整性和商業化需求，這些因素共同定義了負責任地採用鎂基整形外科植入。

總之，鎂合金是整形外科應用中具有戰略意義的重要材料，其臨時機械支撐和良好的生物吸收性能符合臨床目標。合金成分、表面處理和製造技術的進步克服了許多歷史限制，從而實現了更可預測的劣化曲線和更高的機械可靠性。同時，不斷發展的臨床實踐和明確的監管政策正在為負責任的應用鋪平道路，前提是研發人員投資於實證實踐和供應鏈的穩健性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章整形外科植入用鎂合金市場（依植入類型分類）

  • 別針
  • 盤子
    • 壓縮板
    • 鎖板
    • 重組板
  • 桿和釘子
    • 髓內釘
    • 鎖桿
  • 擰緊
    • 鬆質骨螺絲
    • 皮質螺絲
    • 自攻螺絲

第9章 依材質等級分類的整形外科植入用鎂合金市場

  • AZ31
  • Mg-Ca
  • Mg-Zn
  • WE43

第10章 依應用領域分類的整形外科植入用鎂合金市場

  • 顱顎顏面外科
  • 牙科
  • 脊椎
    • 微創手術
    • 開放性手術
  • 運動醫學
  • 創傷
    • 肢體創傷
    • 骨盆創傷

第11章整形外科植入用鎂合金市場（以最終用戶分類）

  • 門診手術中心
  • 醫院
  • 專科診所

第12章 各地區整形外科植入用鎂合金市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章整形外科植入用鎂合金市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國整形外科植入用鎂合金市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國鎂合金整形外科植入市場

第16章 中國整形外科植入用鎂合金市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Alloy OrthoTech Co., Ltd.
  • Bioretec Oy
  • Biotronik SE & Co. KG
  • Bone Solutions Ltd.
  • Dongguan Eontec Co., Ltd.
  • Magmaris Ltd.
  • Magnesis Biomedical GmbH
  • Magnesium Bioabsorbables Pvt. Ltd.
  • Magnesium Development Company Ltd.
  • Magnesium Innovations Inc.
  • MedAlloy Technologies Inc.
  • Medical Magnesium GmbH
  • MetaMag Medical GmbH
  • nanoMAG GmbH
  • Orthos Mg GmbH
  • RegenMag Medical Solutions AG
  • Resomet GmbH
  • Shanghai Rebone Regenerative Medicine Technology Co., Ltd.
  • Syntellix AG
  • U&i Corporation
Product Code: MRR-7B550E008DEA

The Magnesium Alloy for Orthopedic Implants Market was valued at USD 234.15 million in 2025 and is projected to grow to USD 252.94 million in 2026, with a CAGR of 8.27%, reaching USD 408.56 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 234.15 million
Estimated Year [2026] USD 252.94 million
Forecast Year [2032] USD 408.56 million
CAGR (%) 8.27%

An informed overview of how advances in alloy chemistry, surface engineering, and clinical evidence are reshaping the viability of magnesium implants for modern orthopedic care

Magnesium alloys are emerging as a compelling material class for orthopedic implants, driven by their favorable mechanical properties, biodegradability, and compatibility with bone healing physiology. Over recent years, advances in alloy chemistry and surface engineering have improved corrosion control, enabling designers to exploit the unique combination of strength and gradual resorption that aligns with the biological timeline for bone remodeling. This alignment reduces the requirement for secondary removal surgeries in select indications and opens opportunities for novel treatment paradigms where temporary structural support suffices.

Clinically, the material's elastic modulus closer to that of cortical bone and its intrinsic ability to encourage osteogenesis through controlled ion release differentiate magnesium alloys from traditional permanent metals. Concurrently, manufacturers are refining processing routes-from extrusion and forging to additive manufacturing-and surface modification techniques, such as micro-arc oxidation and polymeric coatings, to tailor degradation rates and biological responses. Regulatory bodies have responded by clarifying pathways for bioresorbable metals, which in turn influences study design, clinical evidence generation, and post-market surveillance strategies.

As a result, stakeholders across clinical, industrial, and regulatory domains are actively reassessing product portfolios, R&D priorities, and commercialization roadmaps. Emerging clinical evidence and material science convergence suggest magnesium alloys will increasingly play a strategic role in trauma fixation, spinal applications, and craniomaxillofacial reconstruction, particularly where temporary mechanical support and minimized long-term hardware burden are clinical priorities. Consequently, multidisciplinary collaboration between surgeons, metallurgists, and regulatory specialists is crucial to translate laboratory promise into safe, effective, and commercially viable medical devices.

How converging demands from clinicians, regulators, and healthcare systems are accelerating materials innovation and clinical adoption of magnesium-based orthopedic devices

The orthopedics landscape is undergoing transformative shifts as materials innovation, clinical priorities, and health system economics converge. A notable shift is the increasing clinical emphasis on reducing long-term implant burden; surgeons and patients are seeking solutions that provide sufficient mechanical support during healing and then safely resorb, thereby eliminating the need for hardware removal procedures. This clinical imperative has propelled magnesium alloy research from experimental stages toward device prototypes and early clinical adoption, with continual improvements in corrosion control mitigating historical concerns about rapid degradation.

Meanwhile, surgical practice patterns are evolving with greater adoption of minimally invasive techniques and implant designs optimized for percutaneous delivery. These procedural shifts demand implants with predictable mechanical behavior and surface profiles compatible with soft tissue preservation. Moreover, supply chain resilience and cost pressures have encouraged device developers to streamline material sourcing and processing while maintaining rigorous quality and traceability standards.

Regulatory and reimbursement environments are also adapting; regulators are offering clearer guidance on preclinical and clinical evidence needs for resorbable metals, which in turn influences study design and time-to-market planning. Finally, patient expectations and market access strategies are shaping design priorities: implants must demonstrate not only safety and efficacy but also tangible benefits in patient recovery, reduced secondary procedures, and overall cost-effectiveness. Collectively, these forces are driving a step-change in how companies prioritize magnesium alloys within their innovation pipelines and commercial strategies.

Assessment of how recent tariff dynamics are reshaping supply chain strategies, vertical integration, and procurement decisions across the magnesium implant value chain

Recent tariff developments in the United States have introduced new variables into the supply chain calculus for manufacturers and distributors of magnesium alloy implants. Tariff adjustments influence cost structures across imported raw materials, semi-finished components, and finished devices, which in turn affects sourcing strategies and manufacturing footprints. Many suppliers are responding by evaluating alternative procurement routes, increasing domestic processing capabilities where feasible, and negotiating longer-term contracts to hedge against volatility.

For original equipment manufacturers and component suppliers, tariffs have sharpened the focus on vertical integration and regional diversification. Some companies are investing in localized alloy production and value-added processing to preserve margins and maintain price stability for customers. At the same time, distributors and implant manufacturers are reassessing international partnerships to balance compliance complexity with the need for quality-assured supply lines. These shifts are prompting greater transparency in cost build-ups and influencing pricing negotiations with hospital purchasing groups and healthcare systems.

Crucially, tariffs also affect R&D timelines when specialized feedstock or surface-treatment inputs are sourced internationally; extended lead times and increased costs can slow prototype iterations and clinical validation cycles. In response, stakeholders are prioritizing supply chain risk assessments, scenario planning, and alternative material qualification pathways to minimize disruption. Going forward, strategic supply chain planning and contractual agility will be essential to sustain innovation momentum while managing the commercial implications of tariff-driven cost shifts.

Comprehensive segmentation-driven insights that align implant form factors, clinical applications, distribution pathways, and material grades with commercialization imperatives

A nuanced understanding of product and clinical segmentation is essential to prioritize development and go-to-market efforts for magnesium alloy implants. Implant types include pins, plates, rods and nails, and screws, with plates further differentiated into compression plates, locking plates, and reconstruction plates, rods and nails encompassing intramedullary nails and locking rods, and screws categorized as cancellous screws, cortical screws, and self-tapping screws. Each implant form factor imposes distinct mechanical and degradation performance requirements, influencing alloy selection, heat treatment protocols, and surface finishing approaches.

Application areas span craniomaxillofacial, dental, spinal, sports medicine, and trauma, where spinal use is subdivided into minimally invasive and open surgery approaches and trauma indications include extremities trauma and pelvic trauma. These clinical contexts dictate design constraints such as load-bearing duration, geometry complexity, and biocompatibility thresholds, and they shape clinical trial endpoints and surgeon adoption curves. End users encompass ambulatory surgical centers, hospitals, and specialty clinics, each with different procurement cycles, purchasing power, and clinical workflows that affect adoption timing and required value propositions.

Distribution channels range from direct sales and distributors to e-commerce platforms, and each channel requires distinct commercial models, regulatory compliance touchpoints, and customer engagement strategies. Material grade selection-AZ31, Mg-Ca, Mg-Zn, and WE43-further refines product positioning by aligning corrosion behavior, mechanical performance, and regulatory familiarity with specific clinical use-cases. Together, these segmentation layers form a roadmap for targeted clinical evidence generation, manufacturing prioritization, and tailored commercialization approaches to accelerate clinician acceptance and patient benefit.

How regional regulatory diversity, clinician adoption patterns, and manufacturing capabilities influence commercialization strategies across major global regions

Regional dynamics shape regulatory expectations, clinical adoption patterns, and supply chain strategies for magnesium alloy implants. In the Americas, clinicians and hospital systems are increasingly receptive to innovations that reduce long-term procedural burden, but they require robust clinical evidence and clear regulatory documentation. This region also features concentrated purchasing groups and integrated health systems that can accelerate adoption for products demonstrating clear clinical and economic advantages.

In Europe, Middle East & Africa, regulatory frameworks emphasize rigorous safety evaluation coupled with regional variations in clinical practice and reimbursement structures. Market access strategies here must account for a mosaic of national health authorities and diverse procurement mechanisms. Early clinical adopters in this region can leverage center-of-excellence models to generate real-world evidence that supports broader uptake.

Asia-Pacific presents a heterogeneous landscape with rapid clinical uptake in select markets, strong metal manufacturing capability, and cost-sensitive procurement environments. Localized production and partnerships with regional manufacturers can reduce lead times and improve price competitiveness. Across all regions, harmonizing regulatory submissions and designing post-market surveillance plans that satisfy multiple jurisdictions will be critical to maintaining compliance and demonstrating long-term safety and performance.

Strategic competitive overview highlighting how integrated alloy development, manufacturing excellence, and clinical partnerships are defining market leaders and niche specialists

Competitive dynamics in the magnesium implant space reflect a mix of established orthopedic device companies expanding into bioresorbable metals and specialized material and component developers focusing on alloy innovation and surface treatment technologies. Key players are differentiating through integrated capabilities that combine alloy development, precision manufacturing, and clinical partnerships to accelerate evidence generation. Some firms emphasize proprietary surface coatings and corrosion-control technologies to achieve clinically predictable degradation profiles, while others invest in process control and certification to support scalable production.

Strategic collaboration between device OEMs and material science laboratories has become a common approach to de-risk product development and expedite the translation from bench to bedside. Partnerships with clinical centers for early feasibility studies and investigator-initiated trials are shaping surgeon confidence and informing iterative design improvements. Additionally, suppliers of medical-grade magnesium feedstock and specialized finishing services are building capability portfolios to support device manufacturers' time-to-market objectives.

As evidence accumulates, commercialization strategies are likely to bifurcate: companies with end-to-end capabilities will push toward integrated product offerings with strong clinical support, while niche specialists may capture value by licensing technologies or supplying high-performance alloys and coatings to larger device manufacturers. For purchasers and strategic partners, evaluating a company's depth across alloy metallurgical expertise, quality systems, and clinical evidence generation provides a meaningful signal of long-term viability.

Actionable strategic priorities for manufacturers to align clinical evidence, supply chain resilience, and targeted commercialization efforts for magnesium implants

Industry leaders should adopt a multi-pronged strategy to convert material promise into clinical and commercial success. First, prioritize targeted clinical studies that align implant design, material grade selection, and surgical technique to real-world endpoints valued by surgeons and payers; pragmatic trials and registries that capture functional outcomes and reoperation rates will be particularly persuasive. Second, invest in supply chain resilience by diversifying suppliers of critical feedstock, qualifying regional manufacturing partners, and implementing contractual safeguards that mitigate tariff and logistics exposure.

Third, accelerate regulatory readiness by engaging early with authorities to define acceptable preclinical models and post-market surveillance obligations; clear regulatory strategies reduce uncertainty and expedite market entry. Fourth, develop surgeon-facing education programs and collaborative initiatives with key opinion leaders to demonstrate handling, fixation techniques, and patient selection criteria that optimize clinical outcomes. Fifth, segment go-to-market efforts by matching distribution channels with end-user needs-direct sales models may work well for complex spinal systems, while broader trauma solutions might benefit from distributor networks or digital commerce pathways.

Finally, pursue materials and surface-engineering innovations that balance predictable degradation with mechanical reliability, and consider strategic partnerships or licensing to fill capability gaps. By aligning clinical evidence, manufacturing certainty, and targeted commercialization tactics, companies can materially improve clinician adoption and create defensible positions in a rapidly evolving landscape.

Detailed explanation of research methods that combine clinician interviews, material science literature, regulatory guidance, and supply chain analysis to produce a validated assessment

The research behind this analysis synthesized multiple inputs to construct a balanced, evidence-driven perspective on magnesium alloys in orthopedic implants. Primary research included structured interviews with clinicians across trauma, spinal, and craniomaxillofacial specialties; conversations with materials scientists, regulatory consultants, and device manufacturers; and direct engagements with supply chain and distribution stakeholders to understand procurement dynamics. These qualitative inputs were triangulated with publicly available scientific literature, regulatory guidance documents, and clinical study reports to validate material performance claims and clinical endpoints.

Secondary research focused on technical publications detailing alloy behavior, corrosion mitigation strategies, and biocompatibility data, as well as white papers and consensus statements from professional societies that inform clinical practice. The methodological approach emphasized cross-validation between clinical practice insights and material science findings to ensure recommendations are actionable and relevant to both product development and commercialization leaders.

Analytical rigor was maintained through iterative review cycles with subject-matter experts and by documenting assumptions, data sources, and limitations. Where evidence gaps exist-particularly in long-term comparative outcomes and large-scale post-market surveillance-recommendations advocate pragmatic study designs and real-world evidence collection strategies. The combined methodological approach yields a pragmatic, clinically oriented, and commercially relevant assessment suitable for executive decision-making.

Concise synthesis of material advances, clinical alignment, and commercialization imperatives that define the path to responsible adoption of magnesium-based orthopedic implants

In summary, magnesium alloys represent a strategically important material class for orthopedic applications where temporary mechanical support and biologically favorable resorption align with clinical objectives. Advances in alloy formulations, surface treatments, and manufacturing techniques have addressed many historical limitations, enabling more predictable degradation profiles and improved mechanical reliability. Concurrently, evolving clinical practice and regulatory clarity are creating pathways for responsible adoption, provided that developers invest in evidence generation and supply chain robustness.

The intersection of clinical need, materials innovation, and commercial pragmatism creates clear opportunities for organizations prepared to align R&D investments with targeted evidence strategies and distribution models. By focusing on surgeon engagement, rigorous preclinical and clinical validation, and resilient sourcing strategies, stakeholders can accelerate translation while mitigating risk. Ultimately, the successful commercialization of magnesium-based orthopedic implants will depend on multidisciplinary collaboration and disciplined execution across material science, clinical research, manufacturing, and commercial operations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Magnesium Alloy for Orthopedic Implants Market, by Implant Type

  • 8.1. Pins
  • 8.2. Plates
    • 8.2.1. Compression Plates
    • 8.2.2. Locking Plates
    • 8.2.3. Reconstruction Plates
  • 8.3. Rods & Nails
    • 8.3.1. Intramedullary Nails
    • 8.3.2. Locking Rods
  • 8.4. Screws
    • 8.4.1. Cancellous Screws
    • 8.4.2. Cortical Screws
    • 8.4.3. Self-Tapping Screws

9. Magnesium Alloy for Orthopedic Implants Market, by Material Grade

  • 9.1. AZ31
  • 9.2. Mg-Ca
  • 9.3. Mg-Zn
  • 9.4. WE43

10. Magnesium Alloy for Orthopedic Implants Market, by Application

  • 10.1. Craniomaxillofacial
  • 10.2. Dental
  • 10.3. Spinal
    • 10.3.1. Minimally Invasive
    • 10.3.2. Open Surgery
  • 10.4. Sports Medicine
  • 10.5. Trauma
    • 10.5.1. Extremities Trauma
    • 10.5.2. Pelvic Trauma

11. Magnesium Alloy for Orthopedic Implants Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Magnesium Alloy for Orthopedic Implants Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Magnesium Alloy for Orthopedic Implants Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Magnesium Alloy for Orthopedic Implants Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Magnesium Alloy for Orthopedic Implants Market

16. China Magnesium Alloy for Orthopedic Implants Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Alloy OrthoTech Co., Ltd.
  • 17.6. Bioretec Oy
  • 17.7. Biotronik SE & Co. KG
  • 17.8. Bone Solutions Ltd.
  • 17.9. Dongguan Eontec Co., Ltd.
  • 17.10. Magmaris Ltd.
  • 17.11. Magnesis Biomedical GmbH
  • 17.12. Magnesium Bioabsorbables Pvt. Ltd.
  • 17.13. Magnesium Development Company Ltd.
  • 17.14. Magnesium Innovations Inc.
  • 17.15. MedAlloy Technologies Inc.
  • 17.16. Medical Magnesium GmbH
  • 17.17. MetaMag Medical GmbH
  • 17.18. nanoMAG GmbH
  • 17.19. Orthos Mg GmbH
  • 17.20. RegenMag Medical Solutions AG
  • 17.21. Resomet GmbH
  • 17.22. Shanghai Rebone Regenerative Medicine Technology Co., Ltd.
  • 17.23. Syntellix AG
  • 17.24. U&i Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COMPRESSION PLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COMPRESSION PLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COMPRESSION PLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING PLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING PLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING PLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RECONSTRUCTION PLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RECONSTRUCTION PLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RECONSTRUCTION PLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING RODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING RODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING RODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY CANCELLOUS SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY CANCELLOUS SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY CANCELLOUS SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY CORTICAL SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY CORTICAL SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY CORTICAL SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SELF-TAPPING SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SELF-TAPPING SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SELF-TAPPING SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY AZ31, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY AZ31, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY AZ31, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MG-CA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MG-CA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MG-CA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MG-ZN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MG-ZN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MG-ZN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY WE43, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY WE43, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY WE43, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPORTS MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPORTS MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPORTS MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTREMITIES TRAUMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTREMITIES TRAUMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTREMITIES TRAUMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PELVIC TRAUMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PELVIC TRAUMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PELVIC TRAUMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. GCC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GCC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. GCC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 190. GCC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 191. GCC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 192. GCC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. GCC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 195. GCC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 196. GCC MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. G7 MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. G7 MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. G7 MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 220. G7 MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 221. G7 MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 222. G7 MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 223. G7 MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. G7 MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 225. G7 MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 226. G7 MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. NATO MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. NATO MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. NATO MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 230. NATO MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 231. NATO MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 232. NATO MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 233. NATO MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. NATO MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 235. NATO MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 236. NATO MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY RODS & NAILS, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SCREWS, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA MAGNESIUM ALLOY FOR ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)